Jeremy Curnock-Cook Buys 10,022 Shares of AVITA Medical (ASX:AVH) Stock

AVITA Medical, Inc. (ASX:AVH) insider Jeremy Curnock-Cook purchased 10,022 shares of the stock in a transaction on Thursday, January 22nd. The shares were purchased at an average price of A$1.17 per share, with a total value of A$11,675.63.

AVITA Medical Price Performance

The firm has a market cap of $226.55 million, a price-to-earnings ratio of -5.55 and a beta of 1.54. The company has a debt-to-equity ratio of 0.36, a quick ratio of 9.32 and a current ratio of 8.18.

About AVITA Medical

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc AVITA Medical, Inc was incorporated in 2020 and is headquartered in Valencia, California.